Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Gray M, Shin SS, Silcox J, Flores D, Bolivar D, Irwin AN, Floyd AS, Bratberg J, Boggis JS, Hartung DM, Green TC. “Like it was just everyday business”: A qualitative study of pharmacy-based naloxone and syringe customer experience. Journal of the American Pharmacists Association 2023;63(3):838-846. [doi: 10.1016/j.japh.2023.01.013] PMID: 36872182 PMCID: PMC10198806
  2. Winstead T, Newman A, Maroon E, Banta-Green C. Unmet Needs, Complex Motivations, and Care for People Using Fentanyl in Washington State: A Qualitative Study. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2023
  3. Chaple MJ, Kunins HV, Nass MD, Benjamin AC, Viel CR, Bertone P, Marker L, Warren P, Hartzler B. Exploring the impact of external facilitation using evidence-based implementation strategies for increasing motivational interviewing capacity among outpatient substance use treatment providers. Journal of Behavioral Health Services & Research 2023;51:185-202. [doi: 10.1007/s11414-023-09871-2] PMID: 38030934
  4. Kingston S. Overview and Perspectives of Syringe Services Programs in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, February 2023
  5. Hartzler B. Is it time to broaden community dissemination of cognitive-behavioral therapy for substance use disorders: Charting pathways to ascend the remaining mountainside [commentary]. Clinical Psychology: Science and Practice 2023;30(2):147-149. [doi: 10.1037/cps0000138]
  6. Peavy KM, Adwell A, Owens MD, Banta-Green CJ. Perspectives on medication treatment for opioid use disorder in adolescents: Results from a provider learning series. Substance Use & Misuse 2023;58(1):160-162. [doi: 10.1080/10826084.2022.2136493] PMID: 36371698
  7. Banta-Green C, Duncan M. Treatment Medications for Fentanyl Use Disorder: Prescriber Practices and Support Needs in WA State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2023
  8. Fockele CE, Morse SC, van Draanen J, Leyde S, Banta-Green C, Huynh LN, Zatzick A, Whiteside LK. “That line that just kept moving”: Motivations and experiences of people who use methamphetamine. West J Emerg Med 2023;24(2):218-227. [doi: 10.5811/westjem.2022.12.58396] PMID: 36976607 PMCID: PMC10047723
  9. Carlini B, Garrett S, Kellum L, Nims L. Cannabis Research Report, 2021-2023. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2023
  10. Green TL, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D. Study protocol for the Respond to Prevent Study: A multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies. Substance Abuse 2022;43(1):901-905. [doi: 10.1080/08897077.2021.2010162] PMID: 35213293 PMCID: PMC9720900
  11. Simpson TL, Kaysen DL, Fleming CB, Rhew IC, Jaffe AE, Desai S, Hien DA, Berliner L, Donovan D, Resick PA. Cognitive processing therapy or relapse prevention for comorbid posttraumatic stress disorder and alcohol use disorder: A randomized clinical trial. PLOS One 2022;17(11):e0276111. [doi: 10.1371/journal.pone.0276111] PMID: 36445895 PMCID: PMC9707793
  12. Bhatraju EP, Fuller C, Grekin P, Rockman S, Peavy KM. Mortality in an opioid treatment program. Journal of Psychoactive Drugs 2022;54(1):93-98. [doi:10.1080/02791072.2021.1909189] PMID: 33840354
  13. Lapham GT, Matson TE, Carrell DS, Bobb JF, Luce C, Oliver MM, Ghitza UE, Hsu C, Browne KC, Binswanger IA, Campbell CI, Saxon AJ, Vandrey R, Schauer GL, Pacula RL, Horberg MA, Bailey SR, McClure EA, Bradley KA. Comparison of medical cannabis use reported on a confidential survey vs. documented in the electronic health record among primary care patients. JAMA Network Open 2022;5(5):e2211677. [doi:10.1001/jamanetworkopen.2022.11677] PMID: 35604691 PMCID: PMC9127557
  14. O'Neal TJ, Bernstein MX, MacDougall DJ, Ferguson SM. A conditioned place preference for heroin is signaled by increased dopamine and direct pathway activity and decreased indirect pathway activity in the nucleus accumbens. Journal of Neuroscience 2022;42(10):2011-2024 [doi: 10.1523/JNEUROSCI.1451-21.2021] PMID: 35031576 PMCID: PMC8916759
  15. Doonan SM, Johnson JK, Firth C, Flores A, Joshi S. Racial equity in cannabis policy: Diversity in the Massachusetts adult-use industry at 18-months. Cannabis 2022;5(1):30-41 [doi: 10.26828/cannabis/2022.01.004] PMID: 37287662 PMCID: PMC10212236
  16. Firth C. Calls to Washington Poison Center for Intentional Exposure to Cannabis, 2017-2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2022
  17. Kingston S, Newman A, Banta-Green C. Results from the 2021 WA State Syringe Service Program Health Survey. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, March 2022
  18. Nakata KG, Yin E, Sutlief E, Ferguson SM. Chemogenetic modulation reveals distinct roles of the subthalamic nucleus and its afferents in the regulation of locomotor sensitization to amphetamine in rats. Psychopharmacology 2022;239(2):353-364. [doi: 10.1007/s00213-021-05985-7] PMID: 34549316
  19. Singh S, Banta-Green C, Kingston S. Distribution of Safer Drug Smoking Supplies as a Public Health Strategy. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, January 2022
  20. Firth CL, Carlini B, Dilley J, Guttmanova K, Hajat A. Retail cannabis environment and adolescent use: The role of advertising and retailers near home and school. Health & Place 2022;75:102795. [doi: 10.1016/j.healthplace.2022.102795] PMID: 35344691 PMCID: PMC9189000